logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Cardiovascular Risk Management 1st Edition by Richard Hobbs, Bruce Arroll ISBN 1405155752 9781405155755

  • SKU: BELL-2165716
Cardiovascular Risk Management 1st Edition by Richard Hobbs, Bruce Arroll ISBN 1405155752 9781405155755
$ 31.00 $ 45.00 (-31%)

5.0

68 reviews

Cardiovascular Risk Management 1st Edition by Richard Hobbs, Bruce Arroll ISBN 1405155752 9781405155755 instant download after payment.

Publisher: Wiley-Blackwell
File Extension: PDF
File size: 2.14 MB
Pages: 99
Author: Richard Hobbs, Bruce Arroll
ISBN: 1405155752, 9781405155755
Language: English
Year: 2008
Edition: 1

Product desciption

Cardiovascular Risk Management 1st Edition by Richard Hobbs, Bruce Arroll ISBN 1405155752 9781405155755 by Richard Hobbs, Bruce Arroll 1405155752, 9781405155755 instant download after payment.

Cardiovascular Risk Management 1st Edition by Richard Hobbs, Bruce Arroll - Ebook PDF Instant Download/Delivery: 1405155752, 9781405155755
Full download Cardiovascular Risk Management 1st Edition after payment

Product details:

ISBN 10: 1405155752 
ISBN 13: 9781405155755
Author: Richard Hobbs, Bruce Arroll

  • Practical ABC style
  • Enables doctors to prioritise treatment using risk-scoring systems and holistic recommendations for reducing cardiovascular risk
  • Includes treatment plans for individuals with diabetes, who are at high risk of developing cardiovascular disease
  • How to reduce cardiovascular risk in other specific patient groups
  • Developed by expert groups in different regions of the world

Cardiovascular Risk Management 1st Table of contents:

  • 1. The Epidemiology of Cardiovascular Disease

    • Global burden of CVD
    • Trends in incidence and prevalence
    • Socioeconomic impact
    • Primary and secondary prevention overview
  • 2. Using Guidelines as a Framework for Cardiovascular Risk Management: Comparison of International Recommendations

    • Overview of major international guidelines (e.g., ESC, ACC/AHA, NICE, WHO)
    • Similarities and differences in recommendations
    • Practical application of guidelines in clinical practice
  • 3. Identifying High-Risk Patients

    • Definition of high risk
    • Risk assessment tools and calculators (e.g., Framingham, SCORE, QRISK)
    • Clinical markers of high risk (e.g., established CVD, diabetes, chronic kidney disease)
    • Emerging risk factors and risk enhancers (e.g., Lp(a), hs-CRP, social determinants)
  • 4. Moderate- to Low-Risk Patients: Management Recommendations

    • Stratification of risk
    • Lifestyle interventions for lower-risk individuals
    • When to consider pharmacological intervention
  • 5. High-Risk Patients: Management Recommendations

    • Aggressive lifestyle modifications
    • Intensive pharmacological management
    • Target blood pressure, lipid, and glucose levels
    • Role of antiplatelet therapy
  • 6. Type 2 Diabetes and Metabolic Syndrome Patients: Management Recommendations for Reducing Cardiovascular Risk

    • The unique challenges of diabetes and CVD
    • Glycemic control strategies
    • Blood pressure and lipid management in diabetic patients
    • Newer agents with cardiovascular benefits (e.g., SGLT2 inhibitors, GLP-1 receptor agonists)
  • 7. Lifestyle Changes to Reduce Cardiovascular Risk

    • Dietary interventions (e.g., Mediterranean diet, DASH diet)
    • Physical activity recommendations
    • Smoking cessation strategies
    • Weight management and obesity
    • Stress management and mental health
  • 8. Pharmacotherapy: Improving the Lipid Profile

    • Statins: types, dosages, side effects, and benefits
    • Ezetimibe
    • PCSK9 inhibitors
    • Fibrates and niacin
    • Omega-3 fatty acids
  • 9. Pharmacotherapy: Lowering Blood Pressure

    • Classes of antihypertensive drugs (e.g., ACE inhibitors, ARBs, CCBs, diuretics, beta-blockers)
    • Combination therapy
    • Management of resistant hypertension
    • Blood pressure targets
  • 10. Pharmacotherapy: Lowering Blood Glucose (in relation to CVD)

    • Metformin
    • SGLT2 inhibitors and GLP-1 receptor agonists (emphasis on cardiovascular outcomes)
    • Other antidiabetic agents and their cardiovascular safety
  • 11. Long-Term Management of Cardiovascular Disease (Secondary Prevention)

    • Management post-MI, stroke, and other cardiovascular events
    • Cardiac rehabilitation
    • Adherence to therapy
    • Surveillance and monitoring
  • 12. Managing Cardiovascular Risk in the Future

    • Personalized medicine and genetics
    • New diagnostic tools and biomarkers
    • Emerging therapies and research directions
    • Public health initiatives and population-level interventions

People also search for Cardiovascular Risk Management 1st:

cardiovascular risk management
    
bpac cardiovascular risk management
    
aggressive cardiovascular risk management
    
cardiovascular risk management guidelines
    
cardiovascular risk management in diabetes

 

Tags: Richard Hobbs, Bruce Arroll, Cardiovascular, Management

Related Products